The APOE promoter polymorphism is associated with rebleeding after spontaneous SAH in a Chinese population

Gene

Volumn 563, Issue 1, 2015, Pages 52-55

  Yin, Cheng ^a   Huang, Guang fu ^a   Ruan, Jian ^b   He, Zong ze ^a   Sun, Xiao chuan ^b  

^a Affiliated Cancer Hospital of University of Electronic Science and Technology of China   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

APOE promoter; Chinese; Polymorphism; Rebleeding; SAH

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E (133-149); PEPTIDE FRAGMENT;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROMOTER REGION; SUBARACHNOID HEMORRHAGE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; STATISTICAL MODEL;

ADULT; AGED; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SUBARACHNOID HEMORRHAGE;

EID: 84926420626     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.03.009     Document Type: Article

References (32)

1. Alfieri A., Unterhuber V., Pircher M., Schwarz A., Gazzeri R., Reinert M., Widmer H.R. Psychosocial and neurocognitive performance after spontaneous nonaneurysmal subarachnoid hemorrhage related to the APOE-epsilon4 genotype: a prospective 5-year follow-up study. J. Neurosurg. 2008, 109:1019-1026.
2. Artiga M.J., Bullido M.J., Sastre I., Recuero M., Garcia M.A., Aldudo J., Vazquez J., Valdivieso F. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett. 1998, 421:105-108.
3. Bederson J.B., Connolly E.S., Batjer H.H., Dacey R.G., Dion J.E., Diringer M.N., Duldner J.E., Harbaugh R.E., Patel A.B., Rosenwasser R.H. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40:994-1025.
4. Brilstra E.H., Rinkel G.J., Algra A., van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000, 55:1656-1660.
5. Broderick J.P., Brott T.G., Duldner J.E., Tomsick T., Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994, 25:1342-1347.
6. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 1998, 18:69-71.
7. Celik O., Bay H.H., Arslanhan A., Oroglu B., Bozkurt S.U., Sehirli U.S., Ziyal M.I. Effect of hyperbaric oxygen therapy on cerebral vasospasm: a vascular morphometric study in an experimental subarachnoid hemorrhage model. Int. J. Neurosci. 2014, 124:593-600.
8. Dabus G., Nogueira R.G. Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature. Interv. Neurol. 2013, 2:30-51.
9. D'Souza S. Aneurysmal subarachnoid hemorrhage. J. Neurosurg. Anesthesiol. 2014, (http://www.ncbi.nlm.nih.gov/pubmed/25272066).
10. Dunn L.T., Stewart E., Murray G.D., Nicoll J.A., Teasdale G.M. The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study. Neurosurgery 2001, 48:1006-1010. (discussion 1010-1).
11. Gallek M.J., Conley Y.P., Sherwood P.R., Horowitz M.B., Kassam A., Alexander S.A. APOE genotype and functional outcome following aneurysmal subarachnoid hemorrhage. Biol. Res. Nurs. 2009, 10:205-212.
12. Harrigan M.R., Rajneesh K.F., Ardelt A.A., Fisher W.S. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery 2010, 67:935-939. discussion 939-40.
13. Henderson W.G., Torner J.C., Nibbelink D.W. Intracranial aneurysms and subarachnoid hemorrhage - report on a randomized treatment study. IV-B. Regulated bed rest - statistical evaluation. Stroke 1977, 8:579-589.
14. Hillman J., von Essen C., Leszniewski W., Johansson I. Significance of "ultra-early" rebleeding in subarachnoid hemorrhage. J. Neurosurg. 1988, 68:901-907.
15. Jiang Y., Sun X., Gui L., Xia Y., Tang W., Cao Y., Gu Y. Correlation between APOE -491AA promoter in epsilon4 carriers and clinical deterioration in early stage of traumatic brain injury. J. Neurotrauma 2007, 24:1802-1810.
16. Juvela S., Siironen J., Lappalainen J. Apolipoprotein E genotype and outcome after aneurysmal subarachnoid hemorrhage. J. Neurosurg. 2009, 110:989-995.
17. Kassell N.F., Torner J.C. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 1983, 13:479-481.
18. Kato Y., Kumar A., Chen S. Surgical nuances of clipping after coiling: looking beyond the international subarachnoid aneurysm trial. J. Clin. Neurosci. 2012, 19:638-642.
19. Kissela B.M., Sauerbeck L., Woo D., Khoury J., Carrozzella J., Pancioli A., Jauch E., Moomaw C.J., Shukla R., Gebel J., Fontaine R., Broderick J. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke 2002, 33:1321-1326.
20. Lambert J.C., Berr C., Cottel D., Amouyel P., Helbecque N. APOE promoter polymorphisms and dementia in the elderly. Neurosci. Lett. 2004, 365:116-119.
21. Lanterna L.A., Biroli F. Significance of apolipoprotein E in subarachnoid hemorrhage: neuronal injury, repair, and therapeutic perspectives - a review. J. Stroke Cerebrovasc. Dis. 2009, 18:116-123.
22. Larsen C.C., Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013, 79:307-312.
23. Lasry O., Marcoux J. The use of intravenous Milrinone to treat cerebral vasospasm following traumatic subarachnoid hemorrhage. SpringerPlus 2014, 3:633.
24. Li S., Zhang H., Gao P., Chen Z., Wang C., Li J. A functional mutation at position -155 in porcine APOE promoter affects gene expression. BMC Genet. 2011, 12:40.
25. Naidech A.M., Janjua N., Kreiter K.T., Ostapkovich N.D., Fitzsimmons B.F., Parra A., Commichau C., Connolly E.S., Mayer S.A. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch. Neurol. 2005, 62:410-416.
26. Parmenter B.A., Denney D.R., Lynch S.G., Middleton L.S., Harlan L.M. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms. Mult. Scler. 2007, 13:25-32.
27. Richardson A.E., Jane J.A., Yashon D. Prognostic factors in the untreated course of posterior communicating aneurysms. Arch. Neurol. 1966, 14:172-176.
28. Sangha J., Natalwala A., Mann J., Uppal H., Mummadi S.M., Haque A., Aziz A., Potluri R. Co-morbidities and mortality associated with intracranial bleeds and ischaemic stroke. Int. J. Neurosci. 2014, (http://www.ncbi.nlm.nih.gov/pubmed/?term=Co-morbidities+and+mortality+associated+with+intracranial+bleeds+and+ischaemic+stroke).
29. Tang C., Zhang T.S., Zhou L.F. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis. PLoS One 2014, 9:e99536.
30. Xin X.Y., Ding J.Q., Chen S.D. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis. J. Alzheimers Dis. 2010, 19:1283-1294.
31. Yin C., Ruan J., Jiang L., Zhou S., Sun X. The relationship between rebleeding after spontaneous SAH and APOE polymorphisms in a Chinese population. Int. J. Neurosci. 2012, 122:472-476.
32. Zhou J., Song B., Duan X., Long Y., Lu J., Li Z., Zeng S., Zhan Q., Yuan M., Yang Q., Xia J. Association of BSG genetic polymorphisms with atherosclerotic cerebral infarction in the Han Chinese population. Int. J. Neurosci. 2014, 124:734-740.